FDA Finalizes Guidance for Drug Labeling to Minimize Medication Errors
- May 20, 2022
The Food and Drug Administration (FDA) issued May 18 final guidance that provides drug and biological product sponsors with a set of principles and recommendations for ensuring that product labels are designed to promote safe dispensing, administration, and use.
ARTICLE TAGS
You must be logged in to access this content.